Highlights
EMA has approved only four vaccines namely, Comirnaty of Pfizer/BioNTech, Moderna s Spikevax, Vaxzervria by AstraZeneca-Oxford and Johnson & Johnson s Janssen.
The SII’s CEO Adar Poonawalla had earlier said that the company is confident of receiving approval from the EMA.
New Delhi: The European Medicines Agency (EMA) has not received any application from the COVID-19 vaccine Covishield maker Serum Institute of India (SII) for authorisation. For the COVID-19 vaccine Covishield to be evaluated for use in the EU, the developer needs to submit a formal marketing authorisation application to EMA, which to date has not been received, the EMA said at a press briefing.
Direktestudio: Koronaviruset
aftenposten.no - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aftenposten.no Daily Mail and Mail on Sunday newspapers.
Direktestudio: Koronaviruset
aftenposten.no - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aftenposten.no Daily Mail and Mail on Sunday newspapers.
Direktestudio: Koronaviruset
aftenposten.no - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aftenposten.no Daily Mail and Mail on Sunday newspapers.
Direktestudio: Koronaviruset
aftenposten.no - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aftenposten.no Daily Mail and Mail on Sunday newspapers.